ZYBT Zhengye Corp: ערך חשבונאי למניה

Zhengye Biotechnology focuses on creating advanced veterinary vaccines, utilizing molecular design methods to protect livestock. The company leverages the expertise of Chinese biochemists and physicians, supported by government funding for research. Serving as the primary valuation tool, this chart of quotes on GURU.Markets captured the value of 0.76, confirming the brand's status as a reliable expert in the production of biologicals that enjoy high trust among farmers.

Book value per share determines the portion of equity attributable to a single security, reflecting the actual value of net assets minus liabilities. When analyzing the aggregate book value per share, it is critical to consider that for Zhengye Biotechnology (ZYBT), this metric may be distorted by high R&D expenditures and the cyclicality of the agricultural sector, creating risks of sudden asset write-downs.